Dendrosomal Curcumin Suppresses Metastatic Breast Cancer in Mice by Changing M1/M2 Macrophage Balance in the Tumor Microenvironment |
Shiri, Sadaf
(Immunology Research Center, Tehran University of Medical Sciences)
Alizadeh, Ali Mohammad (Cancer Research Center, Tehran University of Medical Sciences) Baradaran, Behzad (Immunology Research Center, Tehran University of Medical Sciences) Farhanghi, Baharak (Cancer Research Center, Tehran University of Medical Sciences) Shanehbandi, Dariush (Immunology Research Center, Tehran University of Medical Sciences) Khodayari, Saeed (Cancer Research Center, Tehran University of Medical Sciences) Khodayari, Hamid (Cancer Research Center, Tehran University of Medical Sciences) Tavassoli, Abbas (Department of Pathology, Faculty of Veterinary Medicine, Tehran University) |
1 | Bounaama A, Djerdjouri B, Laroche-Clary A, Le Morvan V, Robert J (2012). Short curcumin treatment modulates oxidative stress, arginase activity, aberrant crypt foci, and TGF-1 and HES-1 transcripts in 1, 2-dimethylhydrazine-colon carcinogenesis in mice. Toxicol, 302, 308-17. DOI |
2 | Colombo MP, Trinchieri G (2002). Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev, 13, 155-68. DOI |
3 | Cui Y-L, Li H-K, Zhou H-Y, Zhang T, Li Q (2013). Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer. Asian Pac J Cancer Prev, 14, 1003-7. DOI ScienceOn |
4 | Ghalandarlaki N, Alizadeh AM, Ashkani-Esfahani S (2014). Nanotechnology-applied curcumin for different diseases therapy. Bio Med Res Int, 2014, 394264 |
5 | Hao N-B, Lu M-H, Fan Y-H, et al (2012). Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol, 2012, 948098. |
6 | Heusinkveld M, van der Burg SH (2011). Identification and manipulation of tumor associated macrophages in human cancers. J Translat Med, 9, 216. DOI |
7 | Huang Y, Lei Y, Zhang H, Zhang M, Dayton A (2011). Interleukin-12 treatment down-regulates STAT4 and induces apoptosis with increasing ROS production in human natural killer cells. J Leukocyte Biol, 90, 87-97. DOI |
8 | Jagetia GC, Aggarwal BB (2007). "Spicing up" of the immune system by curcumin. J Clin Immunol, 27, 19-35. DOI |
9 | Kamran MZ, Patil P, Gude RP (2013). Role of STAT3 in cancer metastasis and translational advances. Bio Med Res Int, 2013, 421821. |
10 | Kelloff GJ, Crowell JA, Steele VE, et al (2000). Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr, 130, 467-71. |
11 | Khaniki M, Azizian S, Alizadeh AM, et al (2013). The antiproliferative and anticancerogenic effects of nanocurcumin in rat colon cancer. Tehran Univers Med J, 71, 277-284. |
12 | Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method. Methods, 25, 402-8. DOI |
13 | Martinez FO, Sica A, Mantovani A, Locati M (2007). Macrophage activation and polarization. Frontiers in Bioscience: J Virtual Library, 13, 453-61. |
14 | Medrek C, Ponten F, Jirstrom K, Leandersson K (2012). The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer, 12, 306. DOI |
15 | Mohsenikia M, Alizadeh AM, Khodayari S, et al (2013). The protective and therapeutic effects of alpha-solanine on mice breast cancer. Eur J Pharmacol, 718, 1-9. DOI |
16 | Murray PJ, Wynn TA (2011). Protective and pathogenic functions of macrophage subsets. Nature Rev Immunol, 11, 723-37. DOI ScienceOn |
17 | Niu G, Wright KL, Ma Y, et al (2005). Role of Stat3 in regulating p53 expression and function. Mol Cell Bio, 25, 7432-40. DOI ScienceOn |
18 | Olefsky JM, Glass CK (2010). Macrophages, inflammation, and insulin resistance. Ann Rev Phys, 72, 219-46. DOI |
19 | Sadeghizadeh M, Ranjbar B, Damaghi M, et al (2008). Dendrosomes as novel gene porters-III. J Chem Technol Biotechnol, 83, 912-20. DOI |
20 | Sarbolouki MN, Sadeghizadeh M, Yaghoobi MM, et al (2000). Dendrosomes: a novel family of vehicles for transfection and therapy. J Chem Technol Biotechnol, 75, 919-22. DOI |
21 | Schindler H, Lutz MB, Rollinghoff M, Bogdan C (2001). The production of IFN- by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol, 166, 3075-82. DOI |
22 | Sica A, Mantovani A (2012). Macrophage plasticity and polarization: in vivo veritas. J Clin Invest, 122, 787-95. DOI ScienceOn |
23 | Sica A, Schioppa T, Mantovani A, Allavena P (2006). Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer, 42, 717-27. DOI |
24 | Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S (2007). Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol, 179, 977-83. DOI |
25 | Siveen KS, Sikka S, Surana R, et al (2014). Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochim Biophys Acta, 1845, 136-54. |
26 | Solinas G, Germano G, Mantovani A, Allavena P (2009). Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukocyte Biol, 86, 1065-73. DOI |
27 | Srivastava RM, Singh S, Dubey SK, Misra K, Khar A (2011). Immunomodulatory and therapeutic activity of curcumin. Intern Immunopharmacol, 11, 331-41. DOI |
28 | Tu SP, Jin H, Shi JD, et al (2012). Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res, 5, 205-15. DOI ScienceOn |
29 | Varalakshmi C, Ali AM, Pardhasaradhi B, et al (2008). Immunomodulatory effects of curcumin: In-vivo. Intern Immunopharmacol, 8, 688-700. DOI ScienceOn |
30 | Uddin S, Hussain AR, Manogaran PS, et al (2005). Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene, 24, 7022-30. DOI |
31 | Vasquez-Dunddel D, Pan F, Zeng Q, et al (2013). STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J Clin Invest, 123, 1580-9. DOI |
32 | Vishvakarma NK, Singh SM (2010). Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: implication in antitumor activation of tumor-associated macrophages. Immunol Letters, 134, 83-92. DOI |
33 | Wang W, Wang J, Dong S-f, et al (2010). Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response. Acta Pharmacologica Sinica, 31, 191-201. DOI |
34 | Weiss JM, Ridnour LA, Back T, et al (2010). Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J Exp Med, 207, 2455-67. DOI |
35 | Xu M, Mizoguchi I, Morishima N, et al (2010). Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. J Immunol Res, 2010, 832454. |
36 | Yang C-L, Liu Y-Y, Ma Y-G, et al (2012). Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One, 7, 37960. DOI |
37 | Yu H, Jove R (2004). The STATs of cancer-new molecular targets come of age. Nature Rev Cancer, 4, 97-105. DOI |
38 | Zhang Y, Cheng S, Zhang M, et al (2013b). High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer. PloS One, 8, 76147. DOI |
39 | Yu H, Pardoll D, Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Rev Cancer, 9, 798-809. DOI |
40 | Zhang X, Tian W, Cai X, et al (2013a). Hydrazinocurcumin encapsuled nanoparticles "re-educate" tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression. PloS One, 8, 65896. DOI |
41 | Alizadeh AM, Khaniki M, Azizian S, et al (2012). Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin. European J Pharmacol, 689, 226-32. DOI |
42 | Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007). Curcumin: the Indian solid gold. In The molecular targets and therapeutic uses of curcumin in health and disease (Springer), pp. 1-75. |
43 | Aggarwal BB, Sung B (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci, 30, 85-94. DOI |
44 | Alexandrow MG, Song LJ, Altiok S, et al (2012). Curcumin: a novel stat 3 pathway inhibitor for chemoprevention of lung cancer. Eur J Cancer Prev, 21, 407. DOI |
45 | Alizadeh AM, Shiri S, Farsinejad S (2014). Metastasis review: from bench to bedside. Tumor Biol, 35, 8483-523. DOI |
46 | Antony S, Kuttan R, Kuttan G (1999). Immunomodulatory activity of curcumin. Immunol Invest, 28, 291-303. DOI |
47 | Babaei E, Sadeghizadeh M, Hassan ZM, et al (2012). Dendrosomal curcumin significantly suppresses cancer cell proliferation< i> in vitro and< i> in vivo. Int Immunopharmacol, 12, 226-34. DOI |
48 | Bhattacharyya S, Hossain DMS, Mohanty S, et al (2010). Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cellular Mol Immunol, 7, 306-15. DOI |
49 | Biswas SK, Chittezhath M, Shalova IN, Lim J-Y (2012). Macrophage polarization and plasticity in health and disease. Immunol Res, 53, 11-24. DOI |